AlphaCrest Capital Management LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,912,000
+281.6%
72,489
+1355.3%
0.07%
+173.1%
Q3 2021$501,000
-27.9%
4,981
+1.4%
0.03%
-13.3%
Q2 2021$695,000
-25.8%
4,912
-47.7%
0.03%
-42.3%
Q1 2021$937,000
+346.2%
9,400
+452.9%
0.05%
+205.9%
Q4 2020$210,000
-41.8%
1,700
-32.0%
0.02%
-61.4%
Q1 2020$361,0002,5000.04%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders